Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Neurovascular Devices/Interventional Neurology Market is Anticipated to Grow at a CAGR of 8.10% and is also Expected to Reach USD 3.98 Billion by 2026, Asserts DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

24 Nov, 2021, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

As per DelveInsight Analysis for Neurovascular Devices market, the increasing prevalence of neurological conditions, rising demands for minimally-invasive procedures are some of the key factors, which are expected to increase the overall demand for Neurovascular Devices, thus driving the growth of the Neurovascular Devices market.

LAS VEGAS, Nov. 24, 2021 /PRNewswire/ -- DelveInsight's Neurovascular Devices Market Insights and Forecast report provides the current and forecast Neurovascular Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Neurovascular Devices Market. 

Some of the salient features from the Neurovascular Devices Market report: 

  • As per an analysis by DelveInsight, North America is expected to dominate the overall Neurovascular Devices Market during the forecast period.
  • Major pharma players working proactively in the Neurovascular Devices Market include Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp., and others.
  • DelveInsight estimates that the Global Neurovascular Devices/ Interventional Neurology Market was valued at USD 2.63 billion in 2020, growing at a CAGR of 8.10% during the forecast period from 2021 to 2026, to reach USD 3.98 billion.
  • On April 21, 2021, Medtronic had received the FDA approval for Pipeline Flex Embolization Device with Shield Technology.
  • On January 07, 2019, Terumo Corporation had announced that FDA had granted the Premarket Approval for the novel Intrasaccular Aneurysm Treatment Device for the treatment of intracranial wide-neck bifurcation aneurysms.

To pick on the latest highlights related to Neurovascular Devices Market, get the snapshot of the key highlights entailed in the Neurovascular Devices Market report.

Neurovascular Devices Overview 

Neurovascular Devices/Interventional Neurology devices are devices that comprise coils, stents, clot-retrieving devices and other devices for the treatment of neurovascular disorders such as brain aneurysms and neurovascular thrombectomy. Clot retrieval devices, suction and aspiration devices are used in the removal of blood clots from the arteries and veins of the brain that can also lead to stroke. Neurovascular devices are used for the treatment of disorders that are associated with the blood vessels that carry oxygen-rich blood to the brain region. 

Interested in knowing how the Neurovascular Devices Market will be growing by 2026? Click to get a snapshot of Neurovascular Devices Market Analysis

Neurovascular Devices Market Insight 

Geographically, the global Neurovascular Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination in North America is observed majorly due to the growing cases of neurological disorders in the United States that require treatment through Neurovascular Devices.

Owing to the growing patient population suffering from chronic neurological disorders and the launch and approval of embolization devices in various countries, there is an anticipated growth boost for the Neurovascular Devices market. For instance, on April 14, 2020, Keystone Heart Ltd. had announced that their cerebral embolic protection device, named TRIGUARD 3 had been granted the CE Mark approval. Also, on October 21, 2019, Shape Memory Medical had announced that they had received CE Mark approval for the Trellix embolic coil system. 

On May 07, 2019, Rapid Medical had announced the Food and Drug Administration approval of the novel Temporary Aneurysm Embolization Assist Device, Comaneci, a new category of temporary coil embolization assists devices.

Learn more about the Neurovascular Devices Market Landscape @ Neurovascular Devices Market Landscape

Neurovascular Devices Market Drivers and Barriers

An increase in the prevalence rate of brain aneurysms suffering population, market development related to products and expansions, and the launch as well as approval of new innovative devices will lead to an increased demand for embolization devices, further leading to an increase in the Neurovascular Devices market growth. Apart from that rising incidence of hypertension across the globe leading to brain aneurysms may also lead to significant growth of the Neurovascular Devices market.

The demand for Neurovascular Devices is primarily affected by the outbreak of the COVID-19 pandemic because of the delay in elective surgeries. Undiagnosed and unreported brain aneurysm cases also act as setbacks for the Neurovascular Devices market.

To get a deeper understanding of the driving factors related to the Neurovascular Devices Market, get a snapshot of the Neurovascular Devices Market Dynamics

Scope of the Neurovascular Devices Market Report

Study Period: 2018-2026

Key Companies: Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp.

Neurovascular Devices Market Segmentation

By Product Type

  • Cerebral Embolization and Aneurysm Coiling devices
    • Embolic Coils
    • Flow Diversion Devices
    • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty and Stenting System
    • Embolic Protection Systems
    • Carotid Artery Stents
  • Neurothrombectomy Devices
    • Clot Retrievers
    • Suction devices
    • Vascular Snare
  • Support Devices
    • Micro Catheters
    • Micro Guidewires

By Application

  • Stroke
  • Cerebral Aneurysm
  • Carotid artery Stents
  • Other Diseases

By End-User

  • Hospitals
  • Ambulatory Surgical Centers

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Delveinsight Analysis: Global Neurovascular Devices/Interventional Neurology Market was valued at      USD 2.63 billion in 2020, growing at a CAGR of 8.10% during the forecast period from 2021 to 2026, to reach USD 3.98 billion.

Table of Contents 

1

Neurovascular Devices/Interventional Neurology Market Report Introduction

2

Neurovascular Devices/Interventional Neurology Market Executive summary

3

Regulatory and Patent Analysis

4

Neurovascular Devices/Interventional Neurology Market Key factors analysis

5

Neurovascular Devices Porter's Five Forces Analysis

6

COVID-19 Impact Analysis on Neurovascular Devices Market

7

Neurovascular Devices Market Layout

8

Neurovascular Devices Global Company Share Analysis – Key 3-5 Companies

9

Neurovascular Devices/Interventional Neurology Market Company and Product Profiles


9.1 Johnson & Johnson

9.2 Medtronic

9.3 Stryker

9.4 Terumo Corporation

9.5 Penumbra, Inc.

9.6 Microport Scientific Corporation

9.7 Kaneka Corporation

9.8 Integer Holdings Corporation

9.9 phenox GmbH

9.10 Perflow Medical Ltd.

9.11 Balt

9.12 Rapid Medical

9.13 ASAHI INTECC CO., LTD.

9.14 Acandis GmbH

9.15 Cerus Endovascular Inc.

10

Project Approach

11

KOL Views

12

DelveInsight Capabilities

13

Disclaimer

14

About DelveInsight

Learn more about the report offerings @ Neurovascular Devices Market Outlook

Understand the Competition, Risk Assessment and effective Research and Development approach to take value-based decisions.

Related Reports

Choroidal Neovascularization Pipeline Insights

"Choroidal Neovascularization Pipeline Insights, 2021" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Choroidal Neovascularization market. A detailed picture of the Choroidal Neovascularization pipeline landscape is provided, which includes the disease overview, treatment guidelines, and key companies involved such as Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp, and others.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market was valued at USD 681.36 million in 2020, growing at a CAGR of 6.11% during the forecast period from 2021 to 2026 to reach USD 969.17 million by 2026. The report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends, market drivers, market barriers and key companies involved such as Stryker, Penumbra, Vesalio, Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, and many others.

Neurovascular Coiling Assist Devices Market 

DelveInsight's 'Neurovascular Coiling Assist Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth understanding of Neurovascular Coiling Assist Devices and the historical and forecasted Neurovascular Coiling Assist Devices market trends, market drivers, market barriers and key companies involved such as Acandis GmBH, BALT Extrusion, Johnson & Johnson (Cerenovus), Medtronic Plc, Stryker, Terumo (MicroVention), and others.

Peripheral Vascular Clot Management Interventions Market 

DelveInsight's 'Peripheral Vascular Clot Management Interventions Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of peripheral vascular clot management interventions and the historical and forecasted peripheral vascular clot management interventions market trends, market drivers, market barriers and key companies involved such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, Argon Medical Devices, Inc., Control Medical Technology, B. Braun Melsungen AG., Inari Medical, and others.

Nerve Monitoring Systems Market

Global Nerve Monitoring Systems Market was valued at USD 1.23 billion in 2020, growing at a CAGR of 4.17% during the forecast period from 2021 to 2026, to reach USD 1.72 billion by 2026. The report delivers an in-depth understanding of Nerve Monitoring Systems and the historical and forecasted Nerve Monitoring Systems market trends, market drivers, market barriers and key companies involved such as Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Innopsys Inc, Neurovision Medical Products, NeuroWave Systems Inc, Cadwell Industries, Dr. Langer Medical GmbH, Inomed Medizintechnik GmbH, Symmetry Surgical, Checkpoint Surgical Inc, and many others.

Vascular Access Devices Market 

Global Vascular Access Devices Market was valued at USD 4.31 billion in 2020, growing at a CAGR of 6.64% during the forecast period from 2021 to 2026, to reach USD 6.13 billion by 2026. The report delivers an in-depth understanding of Vascular Access Devices and the historical and forecasted Vascular Access Devices market trends, market drivers, market barriers and key companies involved such as  Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Smiths Group PLC, Nipro Medical Corporation, and many others.

Neurovascular Catheters Devices Market 

DelveInsight's 'Neurovascular Catheters Devices - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Neurovascular Catheters Devices and the historical and forecasted Neurovascular Catheters Devices market trends.  Neurovascular Catheters Devices market will be covered in-depth in the report comprising of company overview, financial overview, product overview and company share analysis of key players.

Browse Through Our Blog Posts

  • Neurovascular Thrombectomy Devices Market
  • Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
  • An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us

Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

Modal title

Also from this source

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Lewy body dementia (LBD) is a progressive neurological condition characterized by the accumulation of abnormal alpha-synuclein protein in the brain....

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

DelveInsight's Anti-GPC3 Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.